Targeting of Mcl-1 in Breast Cancer-Associated Fibroblasts Reverses Their Myofibroblastic Phenotype and Pro-Invasive Properties

Scientists showed that pharmacological inhibition or knock down of MCL-1 in primary breast ancer-associated fibroblasts directly derived from human samples mitigated myofibroblastic features.